Paige Mahaney
Chief Scientific Officer, C4 Therapeutics (United States).
Companies
- C4 Therapeutics (United States)Chief Scientific Officer Oct 29, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
C4 Therapeutics (United States) CCCC336,910 shares2$972.0K at $2.88Feb 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 14, 2026Shares withheld for tax 2,446 shares at $1.89 of C4 Therapeutics (United States)2
- Feb 14, 2026Exercised options 7,050 shares of C4 Therapeutics (United States)2
- Feb 13, 2026Granted 240,000 shares of C4 Therapeutics (United States)2
- Oct 28, 2025Shares withheld for tax 5,644 shares at $2.58 of C4 Therapeutics (United States)3
- Oct 28, 2025Exercised options 19,200 shares of C4 Therapeutics (United States)3
- Feb 14, 2025Granted 28,200 shares of C4 Therapeutics (United States)4
- Oct 28, 2024Granted 76,800 shares of C4 Therapeutics (United States)5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Oct 30, 2025
- 4SEC EDGARForm 4 filed Feb 18, 2025
- 5SEC EDGARForm 4 filed Oct 29, 2024